The slip
PARKINSON RECEIPTno. 12653
28 Oct 2026, 04:16 UTColigodendrocytes, braak
predictionAK5 in oligodendrocytes tracks Braak Lewy-body stage
registeredfd798f49aa0d25f2
discovery+0.01 p=0.982 n=9
replication+0.29 p=0.457 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.01, p 0.982)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT8b0ebc21b9b68f5b7bd751e4…
follows 24060bc01c2b…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 12653: AK5 in oligodendrocytes, braak
- power
- full sample +0.09 (p 0.709, n 18), 95% CI -0.39 to +0.54. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.08 (p 0.754, n 18). does not hold up.
- composition
- oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: +0.06 (p 0.800, n 18). could be the mix.
- skeptic
- leave-one-out range -0.02 to +0.23, sign flips 2; without severely affected donors +0.09 (p 0.709, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for AK5 in oligodendrocytes.
case closed: nothing better to follow up.